Breakthrough study aims to find safer, more accurate way to diagnose chest lymphoma
NCT ID NCT07352267
Summary
This study aims to determine which of two minimally invasive biopsy procedures is better and safer for diagnosing lymphoma in the chest area. Researchers will compare two techniques performed during a bronchoscopy to see which one more reliably provides clear tissue samples for diagnosis. The trial involves 470 adults with unexplained chest lymph node enlargement who are suspected of having new or returning lymphoma.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIASTINAL AND HILAR LYMPHADENOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.